Login to Your Account



Mpex Licenses Rights To Efflux Pump Technology From Trine

By Randall Osborne


Tuesday, August 10, 2004
With a plan to boost the efficacy of antibiotics against particularly deadly and resistant bacterial pathogens, Mpex Pharmaceuticals Inc. licensed rights to Trine Pharmaceuticals Inc.'s patents pertaining to efflux pump inhibitors (EPIs) for undisclosed terms. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription